Key facts
- It has raised $31.8M across 4 recorded rounds; the latest was Buyout/LBO (Add-on)† in Sep 2018.
- Patara Pharma has filed 5 Form Ds with the SEC since 2014, most recently Oct 2016 ($6.0M sold to 37 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Patara Pharma
Create free account
No card required
Funding rounds
4 roundsSep 2018Buyout/LBO (Add-on)†—▮
About Patara Pharma
- Industry
- Other Pharmaceuticals and Biotechnology
PA Mark — not yet priced
Patara Pharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Patara Pharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Patara Pharma in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.